A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study
For the Study Group of Preoperative therapy for Pancreatic cancer (PREP)
Dive into the research topics of 'A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study'. Together they form a unique fingerprint.